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CEnldesmrzn, a protein o~gi~~~~ fond in chicken gizzard, was ~~~~~~ded also to be present in ~~~~~ 
~~~ta~ uterus, and human ~Ia~~~~ts by dam~nst~tion of a ~r~t~j~ with the following properties: (a) 
0”-dependent caimodulin-bindiog; (b) binding to F actin in such way that the binding was broken 01% 
C@-dependent binding of calmodulin; (c) cross-reactivity in immana blotting pracedures with affinity 
purified antibody against gizzard ~~l~~srn~n~ (d) similar subunit M+slues on SDS-gel to those of gi?A&r& 
~~d~srn~~. Like gizzard ~d~sm~~, ~~~t~~et caldesmon was c~m~~~~ of EWO poiypeptide bands of ni%;- 
~~~~ and KWB, but caldesmoa in am-ta and uterus gave a singb ~~~ of ilcf, fS0000. A p~~~~t~d~ 
af && 163 I;xfo that was ~~~~~~~~~~~~ distinct from cafdesmon but, like ~~d~rn~~, bound to c~rnod~~~~ 
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a dual mechanism consisting of phosphorylation 
and dephosphorylation of two of the myosin light 
chains and a caldesmon-linked flip-flop switch for 
the control of the gizzard smooth muscle contrac- 
tile system [l 11. It therefore seemed of particular 
interest to see if caldesmon was present in other 
types of smooth muscle. Here, we examined 
whether it is present in bovine aorta, uterus, and 
human platelets. Platelets were also examined as 
they are similar to smooth muscle in containing 
relatively large amounts of contractile proteins and 
undergo a series of contractile events upon 
stimulation [ 121. 
2. MATERIALS AND METHODS 
2.1. Preparation of calmodulin-binding protein 
fraction 
A calmodulin-binding protein fraction was 
prepared from bovine aorta, uterus, and human 
platelets by the procedure developed for prepara- 
tion of caldesmon from chicken gizzard [4], with a 
slight modification. The following procedures 
were carried out at 4°C. Aorta and uterus (10 g 
each) were homogenized in a Polytron PT 10 
homogenizer (Kinematica, Switzerland) (three 15-s 
operations at an output setting of 7) with 3 
volumes of buffer I consisted of 0.3 M KCl, 2 mM 
ATP, 0.5 mM MgClz, 0.5 mM dithiothreitol, 
50 mM imidazole-HCl (pH 6.9), 0.25 mM 
phenylmethyl-sulfonyl fluoride, 0.1 mM 
diisopropyl fluorophosphate, and 1 ,ug/ml of 
leupeptin. Washed human platelets (2 ml packed 
volume) prepared as described in [13] were 
suspended in 3 volumes of buffer I and disrupted 
by sonication for five 5-s periods in a Sonifier 
Model W-185 (Branson-Sonic Power) at an output 
setting of 5. The homogenate of each tissue was 
centrifuged for 30 min at 50000 x g. The superna- 
tant was adjusted to 60% saturation of ammonium 
sulfate and the resulting precipitate was collected 
by centrifugation and dissolved in 4-5 ml of buf- 
fer II (20 mM Tris-HCl, pH 7.5, 0.1 mM 
dithiothreitol, 0.1 mM EGTA and 0.6 M KCl). 
The solution was clarified by centrifugation for 
30 min at 105000 x g, and the resulting clear 
supernatant (about 3-4 ml) was applied to a col- 
umn (45 x 2 cm) of Sepharose 4B which had been 
equilibrated with buffer II. Material was eluted 
with buffer II and a fraction corresponding to M, 
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100000-500000 was collected. This fraction was 
dialyzed overnight against buffer III (20 mM 
Tris-HCl, pH 7.5, 0.1 mM dithiothreitol, and 
100 mM KCl) plus 0.1 mM EGTA. The solution 
was made 0.2 mM in Ca2+ by adding CaC12 and 
then clarified by centrifugation for 60 min at 
105000 x g. The clear supernatant was subjected 
to affinity column chromatography on 
calmodulin-Sepharose. The column (3 x 1.2 cm) 
was washed with buffer III plus 0.2 mM CaC12, 
and then the calmodulin-binding protein fraction 
was eluted with buffer III plus 1 mM EGTA. 
2.2. Other methods and materials 
Antiserum to chicken gizzard caldesmon was 
produced in rabbits. Caldesmon (1 mg) in 0.5 ml 
of PBS was emulsified with an equal volume of 
complete Freund’s adjuvant and injected into the 
footpads of a rabbit. Two additional injections 
(0.5 mg protein with incomplete Freund’s adju- 
vant) were given on days 28 and 42, and the rabbit 
was bled on day 56. The anti-caldesmon IgG frac- 
tion was prepared from the serum by ammonium 
sulfate precipitation (48% saturation) and then af- 
finity chromatography on caldesmon-Sepharose 
4B, as will be described in detail elsewhere. 
Calmodulin was prepared from bovine brain as in 
[15]. Calmodulin-Sepharose 4B was prepared as in 
[ 161. Caldesmon [4], myosin light chain kinase 
[17], filamin [18], myosin [19], actin [20], and cy- 
actinin [21] were prepared from chicken gizzard 
smooth muscle. F actin was prepared from G actin 
as in [6]. The sources of commercial materials used 
in this work were as follows: Diisopropyl 
fluorophosphate, and phenylmethylsulfonyl 
fluoride from Sigma, leupeptin from the Peptide 
Institute (Osaka), carrier free 1251 (100 mCi/ml) 
from Amersham International, and peroxidase- 
labelled goat anti-rabbit IgG from Miles Immuno- 
chemicals. The concentration of protein was deter- 
mined as in [22]. 
3. RESULTS 
In a ring test, the anti-caldesmon serum obtain- 
ed in this study formed a precipitating complex at 
1: 10000 dilution in PBS; and in an Ouchterlony 
immunodiffusion test, it gave a single precipitin 
band against gizzard caldesmon, but not against 
myosin light chain kinase, cr-actinin, filamin or 
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Fig. 1. Ouchterlony immunodiffusion test of anti- 
caldesmon serum. Each well received 8~1 of protein 
sample: Center well, 1:5 dilution of anti-caldesmon 
serum in PBS; well 1, caldesmon (1.5 mg/ml); 2, myosin 
light chain kinase (1.2 mg/ml); 3, a-actinin 
(1.3 mg/ml); 4, caldesmon (0.75 mg/ml); 5, filamin 
(1.5 mg/ml); 6, myosin (1.6 mg/ml). Protein 
precipitation lines were stained with Coomassie brilliant 
blue. 
myosin, all of which were purified from chicken 
gizzard (fig. 1). 
To determine if proteins related to caldesmon 
are present in tissues other than gizzard, we 
prepared a calmodulin-binding protein fraction 
from each of bovine aorta, uterus, and human 
platelets by affinity column chromatography on 
calmodulin-Sepharose. The method was a 
modification of that used for preparation of the 
Gizzard 
Caldesmon Aorta 
a b c ab c 
caldesmon-containing fraction from chicken giz- 
zard [3]. The proteins in these fractions were 
Platelet Uterus 
a b c a b C 
Fig.2. Detection of caldesmon in aorta, uterus, and platelets. Calmodulin-binding protein fractions from bovine aorta, 
uterus, and human platelets were subjected to SDS-polyacrylamide gel electrophoresis (7.5% polyacrylamide) as in 
[12]. The proteins separated on the gels were then detected in 3 ways: by protein staining with Coomassie brilliant blue 
(lane a); by immune blotting and then the peroxidase reaction (lane b); and by the gel overlay method and then 
autoradiography of bound ‘2s1-calmodulin (lane c). The immune blotting procedure was essentially as in (23). 
Caldesmon or caldesmon-related proteins in the gels were labelled with affinity-purified anti-caldesmon IgG bound to 
peroxidase-labelled goat anti-rabbit IgG. The latter protein was then located by the peroxidase reaction with 
diaminobenzidine and HzOz. The method in [24] was used for the gel overlay technique. ‘Z’I-Calmodulin was bound 
to the calmodulin-binding proteins separated on the gel and detected by autoradiography. ‘Z51-Calmodulin (spec. act. 
6.8 x 10’ cpm/pg) was prepared by a lactoperoxidase method [25]. The following amounts of proteins were loaded per 
slot: purified caldesmon (gizzard), 4 pg; aorta, 3 ,ug; uterus, 5 pg; platelets, 15 pg. 
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separated on polyacryl~ide gels by elec- 
trophoresis in the presence of SDS and then 
located in 3 ways: by staining protein with 
Coomassie blue (fig.& lane a), by immune blotting 
with anti-caldesmon a tibody and then the perox- 
idase reaction (lane b), and by gel overlay with r2*I- 
calmodufin and then autoradiography (lane c). 
Caldesmon purified from gizzard was used as a 
reference. The aorta and uterus gave several bands 
stained with Coomassie, those of M ~&~~O, 
15~~ and ~~~ being most intense (lane aI+ 
The 1~0~ band was strongest with aorta, but the 
165000 band was strongest with uterus. Platdets 
gave a different pattern from aorta or uterus 
smooth muscles: they gave many po~ypeptide 
bands, because more platelet protein was applied 
to the gel slot, and of these bands, those of M, 
150000, lag, 80~, 6oooO and 45000 were 
predominant. 
The immune blotting technique revealed the 
presence of a band of polypeptide of M 150000, 
coincident with that of gizzard caldesmon, in all 
Aorta 
Ca2+ + + - - 
CaM - + - -t 
tissue samples examined (lane b). A doublet form 
of caldesmon of A& 150000 and 147000 was 
detected in gizzard (see also [rij) and platelets, 
whereas a single band of A& I50000 was obtained 
with aorta and uterus. In addition, the colour in- 
tensities of the 150000 bands from aorta and 
uterus observed on immune blotting (lane b) were 
much weaker than suggested from their staining in- 
tensities with Coomassie bfue (lane a) when com- 
pared with those of gizzard and platelet proteins. 
Caldesmon could not be detected by the gel overlay 
method, presumably because this protein did not 
recover a native configuration capabfe of binding 
to calmodulin after exposure to SDS ~submitted~. 
This was confirmed in this study with gizzard 
caldesmon and platelet protein (fig.2 lane c). 
Nowever, the 150000 proteins of aorta and uterus 
were detected by lzsI-c~modulin autoradiography, 
although the intensities of their bands on auto- 
radiography were much weaker than those ex- 
pected from their Coomassie blue-stained counter- 
parts relative to the 165000 bands. Other bands 
Uterus 
+ - - 
+ - -t 
Platetet 
+ (111 
Fig.3. Binding of proteins to F actin ar to calmodulin in a flip-flop fashion depending upon the concentration of Ca’*. 
Ca~mo~~lin-binding protein fractions from aorta (25 gg protein), uterus (37.5 pg protein) and plateiets (50 pg protein) 
were Incubated with 250 gg of gizzard F actin at 30°C for 30 min in medium consisting of 20 mM Tris-HCI (pW 7.5), 
0.5 mM MgCI~, fMf mM KC1, 0.1 mM dithiothreito1 and 0.1 mM ATP in the presence or absence of SOpg of 
calmodulin in a total volume of 25Opf. Either 0.1 mM CaCl2 or 1 mM EGTA, as indicated in the figure, was added. 
After incubation* mixtures were centrifuged at 30°C for 30 min at 105000 x g‘ The resulting peiiets were dissolved in 
2.50~1 of 2% SDS, 100 mM 2-mer~apt~ethano~ and 50% glycerol and the solutions were heated in boiling water for 
3 min and then subjected to Sag-polyacrylamide gel electrophores~s in the buffer system in 1141. The protein bands 
on the gels were detected by Coomassie blue staining (shown here) and immunoblott~n~ procedures (not shown). CaM, 
~almoduiin. 
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were also detected by the gel overlay methud. 
Thus, on au~oradio~aphy~ A& 165ooo was 
pr~~rni~a~t fur aorta and uterus and ~~~ and 
6WX’Xl were the major bands for platelets. 
Next we examined whether these 150000 
potypeptides (or 150000 plus 1470 doublet for 
platelets) could bind to F actin in such a way that 
the binding was abolished by the Ca2’-dependent 
binding of calmodulin to the polypeptides fflip- 
flop bidding)_ As shown in fig.3 (~~#mass~e bfue 
sta~~~n~)~ these ~o~y~ep~~d~ ~~d~~~~t~d with F 
a&in, and addition of ~~modu~i~ n the presence, 
but not in the absence, of c;xz+ ~~rn~~at~ the 
ass~~~tio~ of the ~Iype~tides witfr F a&n. Essen- 
tialXy the same resuks were obtained by the im- 
munoblotting method (not shown). Fig.3 shows 
severeX F actin-binding polypeptides other than the 
c&ldesmon polypeptides. These include the 165 000 
polypeptide from aorta and uterus, and 100000, 
80000 and 60000 poiypeptides from platelets, The 
results also show that ah of them except the 60000 
~oly~~~t~de exhibited binding to F zrctin or to 
~~m~d~lin i  a fIip-t-lop fashion d~~~~di~ upon 
&e ~u~~~ntration f ca=. 
1x1 searching for caldesmon in tissues other than 
chicken gizzard, we used multiple criteria for this 
protein, because polypeptides possessing similar 
properties were found near the bands of culdesmon 
on SDS-ge;els. For instance, a 135000 poiypeptide, 
which is probably myosin light chain kinase [ISI, 
and a ~6~~ ~o~~ept~de (fig.2 and 3) were shown 
to bind to ~~modu~~n a d F a&n in a flip-flop 
~asb~o~- HoWever, these ~o~y~~t~~es could be 
d~s~i~~~~sbed ~rnrn~o~og~~~~y from c&desmon 
(fig.1 and 2). Therefore, the criteric;x we adopted 
for identification of caldesmon were as follows: 
(i) It should be a Ca2+-dependent calrnodulin- 
binding protein with similar subunit Mr-values 
to gizzard caidesmon on SDS-gel, 
(ii) It should be an F actin binding protein and its 
binding to F actin should be eliminated by the 
~~~~-de~endeni bi ding of c~~~uli~_ 
(iii) it shoufd cross-react ~mrn~~olo~j~~II~ with an- 
tibody raised against gizzard ~~~d~rnu~_ 
Nere, we found proteins that fuffified aII these 
criteria in bovine aorta, uterus, and human 
platelets. However, small differences were seen 
ammg these proteins. Cald~mon in ~~~~d and 
pIateIets was compsed of two subunit creep- 
tides with Mr of 150000 and 147 ON?, but 
caldesmon in aorta and uterus gave a single 1513ooO 
polypeptide on SDS-gel. It is uncertain whether 
these proteins have homo-dimeric structures. 
Another difference was that the proteins of aorta 
and uterus were detectable by the gel overlay 
method, ahhough very weakly, while those of @z- 
zard and ~~atel~ts could not be detected by this 
method. ~~eref~r~~ wepropose to name the pro- 
tein in aorta anb uterus s-c.aIdesmon and that in 
gizzard a&i ~1~teIets d-caldesmon. 
The Ca”-dependent regulation by ~~lm~d~lin 
of the function of actin filaments is medi$ted by 
caldesman (see section 1). Thus, caldesmon has 
been proposed to be an important regulator in the 
smooth muscle contractile device [9]. The present 
results demonstrating the presence of caldesmon in 
the aorta, uterus and platelets are compatible with 
this view. Moreover, we recently found by an 
~~u~~~~~b~rn~~~ technique with antj~~ to 
gkard ca~~~s~~n that the indirect ~rnrn~~~~~~r- 
esceace ~u~~~d~ wi& E& C&X&E sress fibers and 
ruffles of cuhured ~brob~~t &Zs (Yabara, X. and 
Kakiuchi, S., ~~pubIished~_ These findings suggest 
the interesting possibility that caldesmon or related 
proteins may also be involved in the control of the 
contractile devices of non-muscle cells. 
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